Royal Marsden Hospital

A UK researcher has streamlined how women at her hospital with ovarian cancer seek genetic testing.

The researchers reported that BRCA2 was the most commonly mutated germline DNA-repair gene in their cohort.

A new study suggests ctDNA in post-treatment blood samples may help predict relapse in early stage breast cancer patients treated with chemotherapy and surgery.

NEW YORK (GenomeWeb News) – A consortium of research centers led by the Institute of Cancer Research, London will partner with Illumina to launch a new sequencing-based testing program to analyze genetic mutations in cancer patients, the Wellcome Trust said today.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.